Link between antidepressants, violence unclear

Posted by Administrator on February 24th, 2006 — in Paxil Top News

Can antidepressants lead people to become violent?
The question has been raised frequently in recent years, often by lawyers representing murder defendants who had been taking drugs, such as Prozac, Paxil and Zoloft.
It surfaced in Charlotte with the stabbing deaths Jan. 20 of 5-year-old twin girls. Their father, David Crespi, who was taking antidepressants and sleeping […]

Antidepressant linked to sudden suicide

Posted by Administrator on February 24th, 2006 — in Paxil Top News

Q: My husband went into the hospital for chest pains on a Sunday. He was kept overnight, and lots of tests were run. After all that, he was told he was physically healthy and probably just had an anxiety attack. He was given Wellbutrin and sent on his way. On Tuesday, he still wasn’t feeling […]

FDA warns of Paxil birth defect risks

Posted by Administrator on February 24th, 2006 — in Paxil Top News

WASHINGTON, Dec. 9 (UPI) — Studies suggest Paxil increases the risk for birth defects if taken in the first trimester of pregnancy, says the U.S. Food and Drug Administration.
The FDA is alerting healthcare professionals and patients about early results of the studies for Paxil, or paroxetine hydrochloride, approved for the treatment of depression and […]

GSK Changes Paroxetine Prescribing Information

Posted by Administrator on February 24th, 2006 — in Paxil Top News

GlaxoSmithKline (NYSE: GSK) has changed the Paxil® (paroxetine hydrochloride) labeling to reflect updated epidemiological studies which show that infants born to women who had first trimester exposure to paroxetine had an increased risk of cardiovascular malformations.
The most common malformations in the studies were ventricular and atrial septal defects.
In general, septal defects range from […]

FDA Issues Public Health Advisory for Paxil Use in Early Pregnancy

Posted by Administrator on February 24th, 2006 — in Paxil Top News

Clinical Relevance: Paroxetine (Paxil and Paxil CR; GlaxoSmithKline) taken in the first trimester of pregnancy was found to increase the risk of congenital malformations in infants (most specifically cardiac anomalies) as compared to the general population as well as to other antidepressants. One unpublished study, based on the Swedish National Registry, demonstrated a two-fold risk […]

3 GSK drugs in short supply

Posted by Administrator on February 24th, 2006 — in Paxil Top News

GlaxoSmithKline has alerted physicians and pharmacists that they may have to ration Coreg, a heart medication that is the only approved treatment for certain high-risk patients.
Two other GSK drugs, diabetes treatment Avandamet and antidepressant Paxil CR, are also in short supply.
The shortages are caused by voluntary safeguards GSK introduced in December at its production plant […]

FDA Advising of Risk of Birth Defects with Paxil

Posted by Administrator on February 24th, 2006 — in Paxil Top News

The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression […]